Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low versus high dose of antimony for American cutaneous leishmaniasis: A randomized controlled blind non-inferiority trial in Rio de Janeiro, Brazil.
Saheki MN, Lyra MR, Bedoya-Pacheco SJ, Antônio LF, Pimentel MIF, Salgueiro MM, Vasconcellos ÉCFE, Passos SRL, Santos GPLD, Ribeiro MN, Fagundes A, Madeira MF, Mouta-Confort E, Marzochi MCA, Valete-Rosalino CM, Schubach AO. Saheki MN, et al. PLoS One. 2017 May 30;12(5):e0178592. doi: 10.1371/journal.pone.0178592. eCollection 2017. PLoS One. 2017. PMID: 28558061 Free PMC article. Clinical Trial.
Sporotrichoid leishmaniasis: a cross-sectional clinical, epidemiological and laboratory study in Rio de Janeiro State, Brazil.
Carvalho LMV, Pimentel MIF, Conceição-Silva F, Vasconcellos ÉCFE, Valete-Rosalino CM, Lyra MR, Salgueiro MM, Saheki MN, Madeira MF, Mouta-Confort E, Antonio LF, Silva AFD, Quintella LP, Bedoya-Pacheco SJ, Schubach AO. Carvalho LMV, et al. Rev Inst Med Trop Sao Paulo. 2017 Jun 1;59:e33. doi: 10.1590/S1678-9946201759033. Rev Inst Med Trop Sao Paulo. 2017. PMID: 28591261 Free PMC article.
Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013).
Brahim LR, Valete-Rosalino CM, Antônio LF, Pimentel MIF, Lyra MR, Paes LEC, Costa ADD, Vieira IF, Dias CMG, Duque MCO, Marzochi MCA, Schubach AO. Brahim LR, et al. Mem Inst Oswaldo Cruz. 2017 Dec;112(12):838-843. doi: 10.1590/0074-02760160478. Mem Inst Oswaldo Cruz. 2017. PMID: 29211245 Free PMC article.
Favorable responses to treatment with 5 mg Sbv/kg/day meglumine antimoniate in patients with American tegumentary leishmaniasis acquired in different Brazilian regions.
Cataldo JI, Conceição-Silva F, Antônio LF, Schubach AO, Marzochi MCA, Valete-Rosalino CM, Pimentel MIF, Lyra MR, Oliveira RVC, Barros JHDS, Pacheco RDS, Madeira MF. Cataldo JI, et al. Rev Soc Bras Med Trop. 2018 Nov-Dec;51(6):769-780. doi: 10.1590/0037-8682-0464-2017. Rev Soc Bras Med Trop. 2018. PMID: 30517530 Free article.
Evaluation of polymerase chain reaction in the routine diagnosis for tegumentary leishmaniasis in a referral centre.
Fagundes A, Schubach A, Paula CC, Bogio A, Antonio Lde F, Schiavoni PB, Monteiro Vde S, Madeira Mde F, Quintella LP, Valete-Rosalino CM, Vasconcellos Ede C, Azeredo-Coutinho RB, Pacheco RS, Marzochi MC, Marzochi KB. Fagundes A, et al. Among authors: antonio lde f. Mem Inst Oswaldo Cruz. 2010 Feb;105(1):109-12. doi: 10.1590/s0074-02762010000100018. Mem Inst Oswaldo Cruz. 2010. PMID: 20209340 Free article.
11 results